Depression and Anxiety Trial, Recruiting NCT06696001 Sponsor: University of North Carolina, Chapel Hill Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06696001
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

As a participant/client:

  • People aged between 18 and 30 years old
  • People who are currently enrolled as a full-time student (undergraduate, graduate, or professional program)
  • People experiencing mild to moderate depression symptoms, as measured by a standard questionnaire called the Beck Depression Inventory (a score between 14 and 28)
  • People who are able to understand what the study involves and agree to take part
  • People who can speak and understand English
  • People who are willing to follow the study's procedures throughout the trial

As a therapist:

  • People aged 18 or older
  • People who are qualified to provide therapy, as determined by the lead researcher
  • People who are able to understand what the study involves and agree to take part
  • People who can speak and understand English
  • People who are willing to follow the study's procedures throughout the trial

Who may not be able to join (participants/clients only):

  • People who have had thoughts of suicide in the past month, as measured by a standard assessment tool
  • People who have ever made a suicide attempt at any point in their life
  • People who have recently started psychotherapy within the past month
  • People who show signs of early psychosis based on a self-report questionnaire, or who have been diagnosed with a psychotic disorder by a mental health professional
  • People who screen positive for autism based on a self-report questionnaire, or who have been diagnosed with autism spectrum disorder by a mental health professional
  • People who take a high daily dose of a type of medication called benzodiazepines (specifically, more than 20 mg of diazepam or its equivalent per day)
  • People who are not able to give free, informed, written consent to participate
  • People who are not able to communicate effectively in English, as assessed during interaction with the study team
  • People who, in the study team's judgment, have any other circumstances that may prevent them from completing the study requirements (confirm with trial site)

There are no exclusion criteria listed for therapists.


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Flavio Frohlich, Carolina Center for Neurostimulation

Phone: (919) 966-4584

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 April 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Inter-brain phase synchronization in Alpha frequency band via Phase Locking Value; Inter-brain phase synchronization in Theta frequency band via Phase Locking Value

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov